诊断放射性同位素市场：以放射性同位素、按应用、成像方式、按适应症、按最终用户、按地区

诊断放射性同位素市场规模预计在 2025 年为 67.4 亿美元，预计到 2032 年将达到 123.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 9%。

由于慢性病发病率的上升、医学影像技术的进步以及对精准诊断程序的需求不断增长，全球诊断放射性同位素市场正在经历显着增长。诊断放射性同位素是用于医学影像诊断各种疾病和病症的放射性物质。这些放射性同位素发射的辐射可被成像仪器侦测到，使医疗专业人员能够观察和分析人体内部结构。

市场动态：

全球诊断放射性同位素市场的动态受多种因素影响。癌症、心血管疾病和神经病变等慢性疾病的发生率不断上升，推动了对诊断放射性同位素的需求。这些放射性同位素用于各种成像技术，例如正子断层扫描 (PET)、单光子发射电脑断层扫描 (SPECT) 和伽马摄影机，以检测和诊断这些疾病。

然而，有几个因素阻碍了市场的成长。诊断用放射性同位素的高成本以及对其生产和使用的严格监管要求，对市场成长构成了挑战。此外，放射性同位素的供应有限，以及某些同位素的半衰期较短，也限制了它们在某些诊断程序中的应用。

儘管面临这些挑战，市场仍提供了许多成长机会。 PET/CT 和 SPECT/CT 等混合成像技术的日益普及预计将推动诊断放射性同位素的需求。此外，新型放射性同位素和放射性药物的开发以及成像技术的进步预计将为市场创造新的机会。

本研究的主要特点

• 本报告对全球诊断放射性同位素市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 全球诊断放射性同位素市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球诊断放射性同位素市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过用于分析全球诊断放射性同位素市场的各种策略矩阵来促进决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 癌症、心血管疾病和神经系统疾病等慢性疾病的盛行率不断上升
  • 限制因素
• 诊断放射性同位素高成本
  • 机会
• 混合成像技术的采用日益增多
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 全球诊断放射性同位素市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 全球诊断放射性同位素市场（以放射性同位素），2020 年至 2032 年

• Technetium-99m
• 铊-201
• 镓-67
• 碘-123
• FDG
• 铷82
• 其他的

6. 2020 年至 2032 年全球诊断放射性同位素市场（依应用）

• 诊断用途
• 治疗用途

7. 2020 年至 2032 年全球诊断放射性同位素市场（以影像方式）

• SPECT
• PET
• β 放射体

8. 2020 年至 2032 年全球诊断放射性同位素市场（依适应症划分）

• 瘤
• 心臟病
• 神经
• 甲状腺
• 整形外科
• 内分泌
• 其他的

9. 2020 年至 2032 年全球诊断放射性同位素市场（依最终使用者划分）

• 医院
• 专科诊所
• 诊断中心
• 学术研究所
• 其他的

第 10 章。 2020 年至 2032 年按地区分類的全球诊断放射性同位素市场

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十一章竞争格局

• GE Healthcare
• Siemens Healthineers
• Koninklijke Philips NV
• Cardinal Health
• Lantheus Holdings, Inc.
• Bayer AG
• Bracco
• Eckert & Ziegler
• Nordion（Canada）Inc.
• NTP Radioisotopes
• Curium
• Jubilant Life Sciences Ltd
• IRE
• Isotopia Molecular Imaging Ltd.
• Mallinckrodt Nuclear Medicine LLC
• Jubilant DraxImage Inc.
• Sumitomo Heavy Industries, Ltd.
• Telix Pharmaceuticals Limited

第十二章 章节

• 调查方法
• 关于出版商

Diagnostic Radioisotopes Market is estimated to be valued at USD 6.74 Bn in 2025 and is expected to reach USD 12.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9% from 2025 to 2032.

The global market for diagnostic radioisotopes is experiencing significant growth due to the increasing prevalence of chronic diseases, advancements in medical imaging technology, and the rising demand for accurate diagnostic procedures. Diagnostic radioisotopes are radioactive substances that are used in medical imaging to diagnose various diseases and conditions. These isotopes emit radiation that can be detected by imaging devices, allowing healthcare professionals to visualize and analyze the internal structures of the body.

Market Dynamics:

The market dynamics of the global diagnostic radioisotopes market are influenced by several factors. The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders is driving the demand for diagnostic radioisotopes. These isotopes are used in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma cameras to detect and diagnose these diseases.

However, there are certain restraints that may hinder the growth of the market. The high cost of diagnostic radioisotopes and the stringent regulatory requirements for their production and use pose challenges for market growth. Additionally, the limited availability of radioisotopes and the short half-life of some isotopes may limit their use in certain diagnostic procedures.

Despite these challenges, the market presents several opportunities for growth. The increasing adoption of hybrid imaging techniques, such as PET/CT and SPECT/CT, is expected to drive the demand for diagnostic radioisotopes. Moreover, the development of novel radioisotopes and radiopharmaceuticals, as well as advancements in imaging technology, are expected to create new opportunities in the market.

Key features of the study:

• This report provides in-depth analysis of the global diagnostic radioisotopes market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global diagnostic radioisotopes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Philips Healthcare , Cardinal Health , Lantheus Medical Imaging, Bayer AG, Bracco Imaging, EczacIbasI-Monrol Nuclear Products , Nordion, Advanced Accelerator Applications, NTP Radioisotopes, Curium Pharma, Jubilant Life Sciences Ltd , IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares, Australian Nuclear Science and Technology Organisation (ANSTO), Eckert & Ziegler Radiopharma GmbH, Isotopia Molecular Imaging Ltd. , Institute of Atomic Energy of Bangladesh , Rosatom State Atomic Energy Corporation, Board of Radiation and Isotope Technology (BRIT)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global diagnostic radioisotopes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diagnostic radioisotopes market

Detailed Segmentation:

• Global Diagnostic Radioisotopes Market, By Radioisotope
  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others
• Global Diagnostic Radioisotopes Market, By Application
  • Diagnostic Application
  • Therapeutic Application
• Global Diagnostic Radioisotopes Market, By Imaging Modality
  • SPECT
  • PET
  • Beta Emitters
• Global Diagnostic Radioisotopes Market, By End User
  • Hospitals
  • Diagnostic Centers
  • Research Institutes
  • Others
• Global Diagnostic Radioisotopes Market, By Indication
  • Cardiology
  • Oncology
  • Neurology
  • Others
• Global Diagnostic Radioisotopes Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profile:
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Cardinal Health
  • Lantheus Medical Imaging
  • Bayer AG
  • Bracco Imaging
  • EczacIbasI-Monrol Nuclear Products
  • Nordion
  • Advanced Accelerator Applications
  • NTP Radioisotopes
  • Curium Pharma
  • Jubilant Life Sciences Ltd
  • IRE - IRE ELiT - Instituto de Pesquisas Energeticas e Nucleares
  • Australian Nuclear Science and Technology Organisation (ANSTO)
  • Eckert & Ziegler Radiopharma GmbH
  • Isotopia Molecular Imaging Ltd.
  • Institute of Atomic Energy of Bangladesh
  • Rosatom State Atomic Energy Corporation
  • Board of Radiation and Isotope Technology (BRIT)

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Diagnostic Radioisotopes, By Radioisotope
  • Market Diagnostic Radioisotopes, By Application
  • Market Diagnostic Radioisotopes, By Imaging Modality
  • Market Diagnostic Radioisotopes, By Indication
  • Market Diagnostic Radioisotopes, By End User
  • Market Diagnostic Radioisotopes, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders
  • Restraints
• High cost of diagnostic radioisotopes
  • Opportunities
• Increasing adoption of hybrid imaging techniques
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Diagnostic Radioisotopes Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Diagnostic Radioisotopes Market, By Radioisotope, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Technetium-99m
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thallium-201
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Gallium-67
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Iodine-123
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• FDG
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Rubidium-82
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Diagnostic Radioisotopes Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Diagnostic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Therapeutic Application
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Diagnostic Radioisotopes Market, By Imaging Modality, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• SPECT
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• PET
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Beta Emitters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Diagnostic Radioisotopes Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Oncology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Cardiology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Neurology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Thyroid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Orthopedic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Endocrinology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Diagnostic Radioisotopes Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021- 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Specialty Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Diagnostic Radioisotopes Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032,( US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, and Y-o-Y Growth, By Radioisotope, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Imaging Modality, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• GE Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lantheus Holdings, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bracco
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eckert & Ziegler
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Nordion (Canada) Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• NTP Radioisotopes
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Curium
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jubilant Life Sciences Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• IRE
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Isotopia Molecular Imaging Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mallinckrodt Nuclear Medicine LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Jubilant DraxImage Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sumitomo Heavy Industries, Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Telix Pharmaceuticals Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us